Gurwith M, Brunton J L, Lank B, Ronald A R, Harding G K, McCullough D W
Am J Med. 1978 Jan;64(1):127-32. doi: 10.1016/0002-9343(78)90188-2.
The results of empiric antibiotic therapy in 126 hospitalized patients with fever during 192 episodes of granulocytopenia were studied. Febrile granulocytopenic patients were randomly allocated to receive either carbenicillin, methicillin and gentamicin, or carbenicillin and cephalothin. The response rate for the two antibiotic regimens was similar, 49 (60 per cent) of 81 responded to the former and 42 (54 per cent) of 78 to the latter. The response rate in patients receiving other antibiotics because of specific indications or counterindications was 19 (58 per cent) of 33. Thirty-nine (35 per cent) of 110 patients who responded to initial antibiotic therapy had an increase in circulating granulocytes of one log10 or more compared to only 10 (12 per cent) of 79 nonresponders with such an increase. The mortality rate in adult patients receiving carbenicillin, methicillin and gentamicin was eight (16 per cent) of 51, compared to 18 (37 per cent) of 49 in those receiving cephalothin and carbenicillin (P less than 0.05). The significance of this difference in the initial response rate or mortality rate between patients treated with the two antibiotic regimens when only patients with documented bacterial infection were considered. Patients who responded to their initial antibiotic regimen, and patients for whose fever no explanation was found, had the best prognosis.
对126例住院期间粒细胞减少症发作192次且伴有发热的患者进行经验性抗生素治疗的结果进行了研究。发热性粒细胞减少症患者被随机分配接受羧苄青霉素、甲氧西林和庆大霉素,或羧苄青霉素和头孢噻吩治疗。两种抗生素治疗方案的有效率相似,81例中49例(60%)对前者有反应,78例中42例(54%)对后者有反应。因特定适应证或禁忌证而接受其他抗生素治疗的患者的有效率为33例中的19例(58%)。110例对初始抗生素治疗有反应的患者中,39例(35%)循环粒细胞增加了1个对数级或更多,而79例无反应者中只有10例(12%)有这种增加。接受羧苄青霉素、甲氧西林和庆大霉素治疗的成年患者死亡率为51例中的8例(16%),而接受头孢噻吩和羧苄青霉素治疗的患者中49例中有18例(37%)死亡(P<0.05)。当仅考虑有记录的细菌感染患者时,两种抗生素治疗方案治疗的患者在初始有效率或死亡率上的差异的意义。对初始抗生素治疗方案有反应的患者,以及发热原因不明的患者,预后最佳。